Triamcinolone
Medication Facts
- Performance enhancing
- Potentially. Single use provides therapeutic value. May enhance performance and/or significantly increase health risks when combined.
- Total hours to clear
- 504
- Frequently used
- N/A
- ESC ID
- TRIAMC-0889
- Trade names
- Kenalog
- Drug type
- Corticosteroid
- Plasma half-life · hours
- 4
- Equine dosing
- 0.1 mg/kg IM, **Joint/SI Injection**
- Cmax · peak plasma concentration
- Unavailable
- Tmax · time to peak plasma concentration
- 12
- ESC concentration guidance
- less than 100 pg/mL to roughly 300 pg/mL (0.1 ng/mL to 0.3 ng/mL). **Due to severe contraindictations consult a licensed veterinarian to discuss treatment options before combining with Betamethasone, Dexamethasone, Methylprednisolne, Isoflupredone, Triamcinolone. If comining these withdrawals must be at least 7 days,
- Primary withdrawal · hours
- 12
- Washout withdrawal · hours
- 168
- ESC control type
- A1 - Generally Controlled - Therapeutic
- Medication report required
- Generally not required, however understand exceptions.
Uses & side effects
Frequenty Used
Product-specific side effects await source review.
Drug interactions
Corticosteroids in horses (e.g., dexamethasone, prednisolone) interact significantly with NSAIDs, increasing gastrointestinal ulceration risk. They also interact with diuretics (furosemide) causing severe potassium depletion, and with vaccines, as immune suppression reduces vaccine efficacy. Use caution with insulin, as steroids increase blood glucose and risk laminitis.